Literature DB >> 28965295

Comprehensive and Methodical: Diagnostic and Management Approaches to Rapidly Progressive Dementia.

Supriya Mahajan1, Brian S Appleby2,3,4.   

Abstract

Purpose of review The sudden emergence of a change in cognitive abilities or behavior is an important symptom that warrants medical evaluation and may represent the early stages of a rapidly progressive dementia (RPD). To correctly ascertain the cause of RPD in a given patient, the clinician must be methodical and knowledgeable about the range of potential causes and must move forward with supportive treatment, and in some cases empiric treatment, based on clinical features alone. Recent findings Significant advances in prion disease biomarkers, the molecular features of rapidly progressive Alzheimer's disease, and new detection of autoimmune limbic encephalitis disease entities have caused a shift in the diagnostic and treatment framework of RPD. Additionally, in the past decade, emerging retrospective data have led to suggested treatments in autoimmune encephalitis that, if instituted early, can protect patients against residual deficits and disease relapse. Summary Here, we provide an integrative clinical and diagnostic treatment approach that is applicable to the various forms of RPD. We have highlighted the clinical features of selected types of RPD that have experienced advances in the last 10-15 years.

Entities:  

Keywords:  Autoimmune encephalitis; Diagnosis; Management; Prion disease; Rapidly progressive dementia; Treatment

Year:  2017        PMID: 28965295     DOI: 10.1007/s11940-017-0474-1

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  68 in total

1.  Rapidly progressive Alzheimer's disease.

Authors:  U M Mann; E Mohr; T N Chase
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

Review 2.  Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis.

Authors:  Myrna R Rosenfeld; Josep O Dalmau
Journal:  Continuum (Minneap Minn)       Date:  2012-04

3.  Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.

Authors:  Agnes van Sonderen; Roland D Thijs; Elias C Coenders; Lize C Jiskoot; Esther Sanchez; Marienke A A M de Bruijn; Marleen H van Coevorden-Hameete; Paul W Wirtz; Marco W J Schreurs; Peter A E Sillevis Smitt; Maarten J Titulaer
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

4.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

5.  Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Authors:  Helena Ariño; Thais Armangué; Mar Petit-Pedrol; Lidia Sabater; Eugenia Martinez-Hernandez; Makoto Hara; Eric Lancaster; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2016-07-27       Impact factor: 9.910

6.  The clinical spectrum of Caspr2 antibody-associated disease.

Authors:  Agnes van Sonderen; Helena Ariño; Mar Petit-Pedrol; Frank Leypoldt; Peter Körtvélyessy; Klaus-Peter Wandinger; Eric Lancaster; Paul W Wirtz; Marco W J Schreurs; Peter A E Sillevis Smitt; Francesc Graus; Josep Dalmau; Maarten J Titulaer
Journal:  Neurology       Date:  2016-07-01       Impact factor: 9.910

7.  Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.

Authors:  Eleanor Drummond; Shruti Nayak; Arline Faustin; Geoffrey Pires; Richard A Hickman; Manor Askenazi; Mark Cohen; Tracy Haldiman; Chae Kim; Xiaoxia Han; Yongzhao Shao; Jiri G Safar; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2017-03-04       Impact factor: 15.887

Review 8.  The Laboratory Diagnosis of Autoimmune Encephalitis.

Authors:  Sang Kun Lee; Soon-Tae Lee
Journal:  J Epilepsy Res       Date:  2016-12-31

9.  Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial.

Authors:  John Collinge; Michele Gorham; Fleur Hudson; Angus Kennedy; Geraldine Keogh; Suvankar Pal; Martin Rossor; Peter Rudge; Durre Siddique; Moira Spyer; Dafydd Thomas; Sarah Walker; Tom Webb; Steve Wroe; Janet Darbyshire
Journal:  Lancet Neurol       Date:  2009-03-09       Impact factor: 44.182

10.  Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice.

Authors:  Karah Nazor Friberg; Gene Hung; Ed Wancewicz; Kurt Giles; Chris Black; Sue Freier; Frank Bennett; Stephen J Dearmond; Yevgeniy Freyman; Pierre Lessard; Sina Ghaemmaghami; Stanley B Prusiner
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-07       Impact factor: 10.183

View more
  1 in total

Review 1.  Rapidly progressive dementias - aetiologies, diagnosis and management.

Authors:  Peter Hermann; Inga Zerr
Journal:  Nat Rev Neurol       Date:  2022-05-04       Impact factor: 44.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.